A novel mutant topoisomerase II alpha present in VP-16-resistant human melanoma cell lines has a deletion of alanine 429.

No abstract is available for this paper.

• Publication year

  1994

• Venue

  Biochemistry

• Publication date

  1994-09-20

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1021/BI00203A030PMID 7727383
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Linker insertion mutagenesis of Drosophila topoisomerase II. Probing the structure of eukaryotic topoisomerase II.

  1994cited by this paper
• Molecular cloning and identification of a point mutation in the topoisomerase II cDNA from an etoposide-resistant Chinese hamster ovary cell line.

  1993cited by this paper
• Modification of DNA topoisomerase II activity via direct interactions with the cyclic adenosine-3',5'-monophosphate response element-binding protein and related transcription factors.

  1993cited by this paper
• Characterization of an unusual mutant of human melanoma cells resistant to anticancer drugs that inhibit topoisomerase II

  1993cited by this paper
• Two independent amsacrine-resistant human myeloid leukemia cell lines share an identical point mutation in the 170 kDa form of human topoisomerase II.

  1992cited by this paper
• Topoisomerase IIα and Topoisomerase IIβ Genes: Characterization and Mapping to Human Chromosomes 17 and 3, Respectively

  1992cited by this paper
• Phosphorylation of topoisomerase II by casein kinase II and protein kinase C: effects on enzyme-mediated DNA cleavage/religation and sensitivity to the antineoplastic drugs etoposide and 4'-(9-acridinylamino)methane-sulfon-m-anisidide.

  1992cited by this paper
• Topoisomerase II alpha and topoisomerase II beta genes: characterization and mapping to human chromosomes 17 and 3, respectively.

  1992cited by this paper
• The role of topoisomerase II in drug resistance.

  1991cited by this paper
• Identification of a point mutation in the topoisomerase II gene from a human leukemia cell line containing an amsacrine-resistant form of topoisomerase II.

  1991cited by this paper
• Expression of a mutant DNA topoisomerase II in CCRF-CEM human leukemic cells selected for resistance to teniposide.

  1991cited by this paper
• Catalytic function of DNA topoisomerase II

  1991cited by this paper
• Increased phosphorylation of DNA topoisomerase II in etoposide-resistant mutants of human cancer KB cells.

  1991cited by this paper
• Attenuated topoisomerase II content directly correlates with a low level of drug resistance in a Chinese hamster ovary cell line.

  1991cited by this paper
• A functional 125-kDa core polypeptide of fission yeast DNA topoisomerase II

  1991cited by this paper
• Evidence that a protein kinase enhances amsacrine mediated formation of topoisomerase II-DNA complexes in murine mastocytoma cell nuclei.

  1991cited by this paper
• Proteolysis patterns of epitopically labeled yeast DNA topoisomerase II suggest an allosteric transition in the enzyme induced by ATP binding.

  1991cited by this paper
• Non-P-glycoprotein-mediated multidrug resistance in a small cell lung cancer cell line: evidence for decreased susceptibility to drug-induced DNA damage and reduced levels of topoisomerase II.

  1991cited by this paper
• Segregation of recombined chromosomes in meiosis I requires DNA topoisomerase II.

  1990cited by this paper
• The role of DNA topoisomerases in recombination and genome stability: a double-edged sword?

  1990cited by this paper
• Decreased nuclear matrix DNA topoisomerase II in human leukemia cells resistant to VM-26 and m-AMSA.

  1990cited by this paper
• Unknotting the complexities of multidrug resistance: the involvement of DNA topoisomerases in drug action and resistance.

  1989cited by this paper
• Structure of the Drosophila DNA topoisomerase II gene. Nucleotide sequence and homology among topoisomerases II.

  1989cited by this paper
• DNA topoisomerase II must act at mitosis to prevent nondisjunction and chromosome breakage

  1989cited by this paper
• DNA topoisomerase poisons as antitumor drugs.

  1989cited by this paper
• Inhibition of protein synthesis reduces the cytotoxicity of 4'-(9-acridinylamino)methanesulfon-m-anisidide without affecting DNA breakage and DNA topoisomerase II in a murine mastocytoma cell line.

  1989cited by this paper
• A protein factor that enhances amsacrine-mediated formation of topoisomerase II-DNA complexes in murine mastocytoma cell nuclei.

  1989cited by this paper
• Characterization and immunological identification of cDNA clones encoding two human DNA topoisomerase II isozymes.

  1989cited by this paper
• Biochemical basis for the interactions of type I and type II topoisomerases with DNA.

  1989cited by this paper
• Mechanisms of the in vivo resistance to adriamycin and modulation by calcium channel blockers in mice.

  1989cited by this paper
• Abrogation of etoposide-mediated cytotoxicity by cycloheximide.

  1988cited by this paper
• A simple salting out procedure for extracting DNA from human nucleated cells.

  1988cited by this paper
• Cloning and sequencing of cDNA encoding human DNA topoisomerase II and localization of the gene to chromosome region 17q21-22.

  1988cited by this paper
• Specific phosphorylation of proteins in pore complex‐laminae from the sponge Geodia cydonium by the homologous aggregation factor and phorbol ester. Role of protein kinase C in the phosphorylation of DNA topoisomerase II.

  1987cited by this paper
• Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.

  1987cited by this paper
• DNA sequence of the E. coli gyrB gene: application of a new sequencing strategy.

  1987cited by this paper
• Purification of topoisomerase II from amsacrine-resistant P388 leukemia cells. Evidence for two forms of the enzyme.

  1987cited by this paper
• DNA topoisomerase II is required for condensation and separation of mitotic chromosomes in S. pombe.

  1987cited by this paper
• Protein kinase C phosphorylates topoisomerase II: topoisomerase activation and its possible role in phorbol ester-induced differentiation of HL-60 cells.

  1986cited by this paper
• DNA damage by antitumor acridines mediated by mammalian DNA topoisomerase II.

  1986cited by this paper
• Nalidixic acid-resistant mutations of the gyrB gene of Escherichia coli

  1986cited by this paper
• Inhibition of calf thymus type II DNA topoisomerase by poly(ADP‐ribosylation).

  1985cited by this paper
• DNA topoisomerases.

  1985cited by this paper
• Phosphorylation of DNA topoisomerase II by casein kinase II: modulation of eukaryotic topoisomerase II activity in vitro.

  1985cited by this paper
• Promotion of daunorubicin uptake and toxicity by the calcium antagonist tiapamil and its analogs.

  1985cited by this paper
• Topoisomerase II is a structural component of mitotic chromosome scaffolds

  1985cited by this paper
• DNA topoisomerase II mutant of Saccharomyces cerevisiae: topoisomerase II is required for segregation of daughter molecules at the termination of DNA replication.

  1984cited by this paper
• Yeast DNA topoisomerase II is encoded by a single-copy, essential gene.

  1984cited by this paper
• A catalogue of splice junction sequences.

  1982cited by this paper
• A homogeneous type II DNA topoisomerase from HeLa cell nuclei.

  1981cited by this paper
• DNA gyrase: purification and catalytic properties of a fragment of gyrase B protein.

  1979cited by this paper
• A topoisomerase from Escherichia coli related to DNA gyrase.

  1979cited by this paper

• Understanding Cancer’s Defense against Topoisomerase-Active Drugs: A Comprehensive Review

  2024cites this paper
• Structural and Biochemical Basis of Etoposide-Resistant Mutations in Topoisomerase IIα

  2022cites this paper
• Variations Related to Resistance of Cancer Cells to Topoisomerase II Alpha Inhibitory Drugs

  2018cites this paper
• Efecto del hidroxitirosol sobre la cardiotoxicidad producida por doxorubicina

  2013cites this paper
• DNA topoisomerase II enzymes as molecular targets for cancer chemotherapy.

  2010cites this paper
• Depletion and mutation of topoisomerase II in animal cells.

  2009cites this paper
• DNA Topoisomerases

  2009cites this paper
• DNA Topoisomerase II«Gene Expression under Transcriptional Control in Etoposide/Teniposide-resistant Human Cancer Cells1

  2006cites this paper
• Characterization of human NSCLC cell line with innate etoposide‐resistance mediated by cytoplasmic localization of topoisomerase II alpha

  2005cites this paper
• Etoposide: discovery and medicinal chemistry.

  2004cites this paper
• Molecular Pathways of Drug Resistance

  2004cites this paper
• Modulation of drug sensitivity in yeast cells by the ATP-binding domain of human DNA topoisomerase IIalpha.

  2003cites this paper
• The molecular biology of topoisomerase IIα and its importance in the acquisition of multidrug resistance in cancer

  2002cites this paper
• Pharmaceutical biotechnology

  2002cites this paper
• Hypophosphorylation of Topoisomerase IIα in Etoposide (VP‐16)‐resistant Human Carcinoma Cell Lines Associated with Carboxy‐terminal Truncation

  2001cites this paper
• Analysis of etoposide binding to subdomains of human DNA topoisomerase II alpha in the absence of DNA.

  2001cites this paper
• Functional and Regulatory Characteristics of Eukaryotic Type II DNA Topoisomerase

  2001cites this paper
• Characterization of cell lines resistant to topoisomerase targeting drugs and mechanistic studies of Quinoxaline solid tumor drugs - a new chemical class of topoisomerase II poisons /

  2001cites this paper
• Modulation of DNA topoisomerase II activity and expression in melanoma cells with acquired drug resistance

  2000cites this paper
• A truncated cytoplasmic topoisomerase IIα in a drug‐resistant lung cancer cell line is encoded by a TOP2A allele with a partial deletion of exon 34

  2000cites this paper
• Topoisomerase II‐alpha expression in melanocytic nevi and malignant melanoma

  2000cites this paper
• EXPERIMENTAL STUDY OF ETOPOSIDE- AND RADIATION-INDUCED APOPTOSIS AND TOPOISOMERASE II α EXPRESSION

  1999cites this paper
• The chemoresistance of human malignant melanoma: an update.

  1999cites this paper
• Structural organization of the human TOP2A and TOP2B genes.

  1998cites this paper
• Cellular resistance to topoisomerase-targeted drugs: from drug uptake to cell death.

  1998cites this paper
• Sequence-specific poisons of type II DNA topoisomerases

  1998cites this paper
• DNA topoisomerase: the key enzyme that regulates DNA super structure.

  1998cites this paper
• Drug resistance to topoisomerase II inhibitors.

  1998cites this paper
• Immunohistochemical staining for DNA topoisomerase IIa in Hodgkin's disease.

  1998cites this paper
• Topoisomerase II levels and drug response in small cell lung cancer.

  1997cites this paper
• Human DNA topoisomerase II-alpha: a new marker of cell proliferation in invasive breast cancer.

  1997cites this paper
• Cellular adaptation to drug exposure: evolution of the drug-resistant phenotype.

  1997cites this paper
• Antitopoisomerase drug action and resistance.

  1996cites this paper
• Decreased DNA topoisomerase II alpha expression and cold-sensitive growth in a mouse mammary cancer cell line resistant to etoposide and doxorubicin.

  1996cites this paper
• Ectopic expression of inactive forms of yeast DNA topoisomerase II confers resistance to the anti-tumour drug, etoposide.

  1996cites this paper
• Human DNA topoisomerase II: biochemistry and role in chemotherapy resistance (review).

  1996cites this paper
• Effect of transfection of a Drosophila topoisomerase II gene into a human brain tumour cell line intrinsically resistant to etoposide.

  1996cites this paper
• Cellular resistance to topoisomerase poisons.

  1996cites this paper
• Verapamil suppresses the emergence of P‐glycoprotein‐mediated multi‐drug resistance

  1996cites this paper
• Cytoplasmic localization of a mutant M(r) 160,000 topoisomerase II alpha is associated with the loss of putative bipartite nuclear localization signals in a drug-resistant human lung cancer cell line.

  1995cites this paper
• Increased rate of adenosine triphosphate-dependent etoposide (VP-16) efflux in a murine leukemia cell line overexpressing the multidrug resistance-associated protein (MRP) gene.

  1995cites this paper
• Topoisomerase II as a target for anticancer chemotherapy.

  1995cites this paper
• Acquisition of multiple copies of a mutant topoisomerase IIα allele by chromosome 17 aneuploidy is associated with etoposide resistance in human melanoma cell lines

  1995cites this paper
• DNA topoisomerase II alpha gene expression under transcriptional control in etoposide/teniposide-resistant human cancer cells.

  1995cites this paper
• Chromosomes and expression mechanisms

  1995cites this paper
• Mechanisms of resistance to topoisomerases poisons.

  1995cites this paper
• DNA topoisomerase II mutations and resistance to anti‐tumor drugs

  1995cites this paper
• with the Loss of Putative Bipartite Nuclear Localization Signals in a Drug-resistant Human Lung Cancer Cell Line1

  1995influential citation
• DNA Topoisomerase IIα Gene Expression under Transcriptional Control in Etoposide/Teniposide-resistant Human Cancer Cells

  1995cites this paper